Helen C. Adams - 14 Nov 2021 Form 4 Insider Report for Prometheus Biosciences, Inc.

Role
Director
Signature
/s/ Timothy K. Andrews, attorney-in-fact for Helen C. Adams
Issuer symbol
N/A
Transactions as of
14 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 20:17:34 UTC
Next filing
15 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +1,083 $0.000000 1,083 14 Nov 2021 Common Stock 1,083 $36.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the first anniversary of the vesting commencement date measured from November 14, 2021, subject to the Reporting Person's continued service with the Issuer on such vesting date.